Yucca Health Review: What the $125-a-Month 'For Life' Price Actually Commits You To

Yucca Health's own description, repeated with slightly different wording on its homepage and its FAQ page, calls it a telehealth platform connecting you with licensed providers and pharmacies for personalized, compounded treatments, best known for GLP-1 weight management but also supporting other health needs with what it calls tailored, science-backed care. Its main weight-loss products are compounded Semaglutide and compounded Tirzepatide, which are not FDA-approved, and it also sells NAD+ and Sermorelin under what it calls separate Longevity and Muscle Recovery categories. Neither NAD+ nor Sermorelin is FDA-approved.

Yucca's FAQ says you may qualify with a Body Mass Index of 30 or higher, or 27 or higher with certain weight-related conditions such as hypertension, type 2 diabetes, high cholesterol, sleep apnea, or cardiovascular disease, and that with a BMI above 25 you may still qualify depending on your medical history, with a licensed provider making the final determination. It is explicit that a prescription is not guaranteed: prescriptions are issued at the sole discretion of a licensed provider, based on your health history and consultation, with no guarantee of approval or of ongoing treatment for a specific duration.

As of September 11, 2026, Yucca's homepage and its Semaglutide product page both show a badge reading "$125/mo For life," marked "*SEMA 6 month plan." The Semaglutide page's pricing table lists three plans: $125 a month on the 6-month plan, billed $750 every 6 months; $140 a month on the 3-month plan, billed $420 every 3 months; and $146 a month on the monthly plan, billed monthly with no commitment. The Tirzepatide page shows the same kind of badge at "$225/mo For life," marked "*TIRZ 6 month plan," and lists $225 a month on the 6-month plan ($1,350 every 6 months), $248 on the 3-month plan ($744 every 3 months), and $258 on the monthly plan. Yucca's homepage pricing FAQ states the 6-month and month-to-month figures for both drugs in writing and says pricing is shared after intake once eligibility is confirmed. The product pages also say "Same price, every dose. For life." Yucca's Terms of Service, last updated August 13, 2026, say pricing may change from time to time and that promotional discounts may be offered. Compounded semaglutide and tirzepatide are not FDA-approved.

Yucca's homepage lists both Sermorelin and NAD+ as "Starting at $158/mo." The NAD+ and Sermorelin product pages show that $158 a month is the 3-month plan rate, billed $475 every 3 months, with the monthly plan at $215 a month for NAD+ and $199 a month for Sermorelin. The treatment picker that appears across Yucca's site, including its homepage and FAQ page, shows NAD+ "As low as $215" and Sermorelin "As low as $199," the monthly plan figures, so the lowest price you see depends on which part of the site you are looking at. Confirm which plan a price refers to before you check out. Yucca's NAD+ and Sermorelin are not FDA-approved.

Yucca's homepage describes a three-step process: a licensed provider reviews everything you have shared and, if appropriate, prescribes a plan built around your goals, and your prescription is then fulfilled by state-licensed pharmacies, with a certificate of analysis available on request. Its FAQ adds detail on timing and billing: subscriptions are billed monthly or quarterly and automatically renew until the end of your six-month prescription, with renewals processed 5 to 7 days early, and you are only charged after your provider approves your treatment.

Yucca's FAQ says it does not accept insurance. It mentions HSA and FSA funds as an option, but says Yucca does not provide itemized receipts or letters of medical necessity. Its Terms of Service state that all sales are final once your card is charged, that compounded medications cannot be canceled or refunded once the prescription has been transmitted to the pharmacy, and that a subscription cancellation stops future charges only, without refunding charges already processed or orders already in progress. Yucca's FAQ and Terms both say refunds are limited to billing errors, duplicate charges, or cases where a provider does not approve your treatment, and the FAQ says compounded medications cannot be returned once shipped since they are custom-prepared. Compounded medications are not FDA-approved.

Yucca's homepage and each of its product pages carry an identical sentence describing its compounded medications as containing the active pharmaceutical ingredients, or APIs, found in brand-name drugs. Its FAQ page names those brand-name drugs as Ozempic, Wegovy, or Zepbound. Ozempic is FDA-approved for type 2 diabetes, and Wegovy and Zepbound are FDA-approved for weight management; Yucca's compounded semaglutide and tirzepatide are not FDA-approved. On every one of those pages, Yucca pairs the ingredient statement with a disclosure in the same sentence or the one right after it: compounded medications are not FDA-approved and do not undergo FDA review for safety, effectiveness, or manufacturing quality. Treat the ingredient claim as Yucca's own description, not an FDA finding.

Yucca's product pages also cite average weight-loss figures: the Semaglutide page states a 14.9% average weight loss and the Tirzepatide page a 20.9% average, each footnoted only to the New England Journal of Medicine, and the same pages carry headlines reading "Lose up to 15% of your weight" and "Lose up to 20% of your weight." Yucca does not name the study, trial population, or dose behind either figure, or say whether the research used its compounded product. Treat all of these as company-reported claims, not a promised result.

Yucca's homepage carries a testimonial carousel with before-and-after photos and specific pound totals next to each photo. One testimonial reads, "I have lost a total of 100 lbs using semaglutide! This has been life changing for me." As of September 11, 2026, a search of the Yucca homepage, FAQ, Terms of Service, and Semaglutide and Tirzepatide product pages found no results-may-vary or individual-results language. Read any single testimonial as one person's account, not a typical or promised result. Yucca's semaglutide is compounded, and compounded drugs are not FDA-approved.

Yucca's FAQ page carries a "Last Updated" date of September 1, 2025, more than a year before this check, while its Terms of Service carry a date of August 13, 2026. The two describe billing differently: the FAQ says subscriptions are billed monthly or quarterly, while the Terms say monthly, quarterly, or 6-month. If a detail on the FAQ conflicts with the Terms or with what you are told during your intake, ask which one is current.

Yucca may suit you if you are comfortable paying for a 6-month plan in one bill to get its lowest advertised rate, and you do not need insurance billing. If you would rather pay month to month, the rate is higher: $146 a month for Semaglutide against $125 on the 6-month plan, and $258 a month for Tirzepatide against $225 on the 6-month plan. Both are compounded, and compounded drugs are not FDA-approved. Its FAQ says it ships only within the United States and requires a residential or business address.

Before you check out, get three things directly from Yucca rather than from a single page: your exact monthly price and total commitment length for the plan you are choosing, since the homepage and the treatment picker show different figures for NAD+ and Sermorelin; how the "for life" badge fits with its Terms, which say pricing may change from time to time; and its current refund terms, since its Terms say all sales are final and refunds are issued only for duplicate charges, billing errors, or when a provider does not approve treatment.

We don't currently list Yucca Health in our rankings. This page carries no tracked links, and we earn nothing if you sign up for Yucca's program.

Is Yucca Health legitimate?

Yucca Health is operating as of September 11, 2026, with a live site and a published eligibility process, and it says licensed providers review your intake. Its Terms of Service name the operator as Brand Merchants Network LLC, doing business as Yucca Health, in Beverly Hills, California. Whether it fits you is a separate question: its $125-a-month Semaglutide badge is the 6-month plan price, and its compounded semaglutide and tirzepatide are not FDA-approved, so confirm your exact price and plan length before you check out.

How much does Yucca Health cost?

As of September 11, 2026, Yucca's badge shows Semaglutide at $125 a month "For life," marked as the 6-month plan; its Semaglutide page lists $125 a month on the 6-month plan ($750 every 6 months), $140 on the 3-month plan ($420 every 3 months), and $146 on the monthly plan. Tirzepatide is $225 a month on the 6-month plan ($1,350 every 6 months), $248 on the 3-month plan ($744 every 3 months), and $258 on the monthly plan. NAD+ and Sermorelin are $158 a month on a 3-month plan ($475 every 3 months), or $215 and $199 a month on their monthly plans. Compounded semaglutide and tirzepatide are not FDA-approved, and neither are Yucca's NAD+ and Sermorelin.

Are Yucca Health's medications FDA-approved?

No. Yucca's own pages state that its compounded medications are not FDA-approved and do not undergo FDA review for safety, effectiveness, or manufacturing quality. Its FAQ names Ozempic, Wegovy, and Zepbound as the brand-name drugs whose active ingredients it says its compounded medications contain. Ozempic is FDA-approved for type 2 diabetes, and Wegovy and Zepbound for weight management; Yucca's compounded semaglutide and tirzepatide are not.

Does Yucca Health accept insurance?

No. Yucca's FAQ says it does not accept insurance. It mentions HSA and FSA funds as an option, but says Yucca does not provide itemized receipts or letters of medical necessity.

Can I get a refund from Yucca Health?

Yucca's Terms of Service, last updated August 13, 2026, say all sales are final and that compounded medications cannot be canceled or refunded once the prescription has been transmitted to the pharmacy. Its Terms and FAQ both say refunds are limited to billing errors, duplicate charges, or cases where a provider does not approve your treatment, and cancelling a subscription stops future charges only. Compounded medications are not FDA-approved.

What weight-loss results does Yucca Health report?

Yucca's Semaglutide page cites a 14.9% average weight loss and its Tirzepatide page a 20.9% average, both footnoted to the New England Journal of Medicine without naming the study or saying whether the research used its compounded product, and the same pages carry the headlines "Lose up to 15% of your weight" and "Lose up to 20% of your weight." These are company-reported claims, not a promised result, and compounded semaglutide and tirzepatide are not FDA-approved. Its homepage also carries individual testimonials with specific pound totals; treat those as single accounts, since no results-may-vary language appears on the pages we checked.